甲状旁腺自体移植新部位以更好评估移植腺体功能:前瞻性随机对照试验研究方案
本研究为前瞻性随机对照试验,计划纳入280例甲状腺切除术后需行甲状旁腺自体移植的患者,随机分为传统部位移植组(A组,140例)与靠近肘前静脉的新部位移植组(B组,140例)。研究将定期监测双前臂血清甲状旁腺激素(PTH)与钙离子浓度共12个月,主要结局为移植腺体存活,次要结局为甲状旁腺功能减退。
要点
- 比较双前臂PTH浓度可评估移植甲状旁腺功能。
- 移植腺体存活定义为移植侧与非移植侧前臂PTH比值不低于1.5。
- 甲状旁腺功能减退定义为非移植侧前臂PTH低于15 pg/ml。
核心结论
- 靠近头静脉的移植部位可能更有利于准确评估移植甲状旁腺的功能,本研究旨在通过随机对照试验确认更有效、准确的评估体系。
研究设计与样本
- 前瞻性随机对照试验,计划纳入280例患者,随机分为传统部位移植组(A组,140例)与新部位(靠近肘前静脉)移植组(B组,140例)。
- 定期监测双前臂血清PTH与钙离子浓度,随访12个月。
- 试验注册于ClinicalTrials.gov,ID为NCT02906748,注册日期2016年3月16日。
主要发现
- 研究方案阶段,尚未报告试验结果。
- 前期初步研究提示,在新部位行甲状旁腺自体移植的患者血清PTH浓度更高。
关键数值与推荐
- 主要结局为移植腺体存活,定义为移植侧与非移植侧前臂PTH比值不低于1.5。
- 次要结局为甲状旁腺功能减退,定义为非移植侧前臂PTH低于15 pg/ml(正常范围15-65 pg/ml)。
- 计划样本量为280例,两组各140例。
临床怎么用
- 通过比较移植侧与非移植侧前臂的PTH浓度,可更准确评估移植甲状旁腺的功能。
- 更准确的PTH测量有助于术后患者管理及识别影响甲状旁腺自体移植成功的因素。
局限性
- 原文未报告试验结果,方案设计的实际可行性及结论尚待验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypoparathyroidism is one of the most common complications encountered in thyroidectomy. In addition to parathyroid in-situ preservation, parathyroid autotransplantation (PA) is another important remedial method for patients whose parathyroid glands have been removed. However, an accurate evaluation method for the function of a transplanted parathyroid is lacking. Our preliminary study indicated that patients with PA at novel sites near antecubital veins had higher serum concentrations of parathyroid hormone (PTH). Therefore, the main hypothesis is that a grafted site closer to the cephalic vein is more useful for better evaluation of transplanted parathyroid function. This study aims to confirm the more efficient and accurate evaluation system through a prospective, randomized controlled trial. METHODS: In total, 280 patients will be enrolled in this study and randomly divided into two groups: 140 patients with transplanted parathyroid glands in the traditional sites (group A) and the other 140 transplanted in the novel sites (group B), close to the antecubital veins. The serum concentration of PTH and calcium ion from both forearms will be measured and monitored regularly for 12 months. The primary outcome of this trial will be the survival of grafted glands, defined as the ratio of PTH between the grafted vs. the non-grafted forearms being no less than 1.5. The secondary outcome is hypoparathyroidism, defined as the PTH level from the non-grafted forearms being less than 15 pg/ml (normal range 15-65 pg/ml). DISCUSSION: Our results from this study should provide a more accurate method to evaluate the function of transplanted parathyroid glands by comparing PTH concentrations in both the grafted and non-grafted forearms following PA at novel sites. A better PTH measurement is helpful not only for the management of postoperative patients, but also for further identification of factors affecting PA success. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02906748 . Registered on 16 March 2016.
引用
- Cui Q, Kong D, Li Z, et al. Parathyroid autotransplantation at a novel site for better evaluation of the grafted gland function: study protocol for a prospective, randomized controlled trial. Trials. 2019. PMID: 30704522. doi:10.1186/s13063-019-3195-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。